Randomized Phase III of PRRT Versus Interferon
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus interferon α-2b in patients with progressive, unresectable, non-pancreatic gastrointestinal neuroendocrine tumors resistant to therapy with somatostatin analogues, in terms of disease control.
创建时间：
2014-12-15
